--- type: "News" locale: "en" url: "https://longbridge.com/en/news/282805486.md" description: "At the close of the Hong Kong stock market, the Hang Seng Index rose by 0.29%, and the Tech Index increased by 1.23%. Innovative drug stocks performed strongly, and tech stocks rebounded. XUANZHUBIO-B rose by 10.5%, JD increased by 4.6%, and both Alibaba and Baidu rose by more than 3%" datetime: "2026-04-15T08:08:59.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282805486.md) - [en](https://longbridge.com/en/news/282805486.md) - [zh-HK](https://longbridge.com/zh-HK/news/282805486.md) --- # At the close of the Hong Kong stock market, the Hang Seng Index rose by 0.29%, the Tech Index rose by 1.23%, innovative drugs increased, and tech stocks rebounded. XUANZHUBIO-B (02575.HK) rose by 10.5%, JD (09618.HK) rose by 4.6%, and Alibaba (09988.HK) and Baidu (09888.HK) rose by over 3% ### Related Stocks - [02575.HK](https://longbridge.com/en/quote/02575.HK.md) - [09888.HK](https://longbridge.com/en/quote/09888.HK.md) - [09988.HK](https://longbridge.com/en/quote/09988.HK.md) - [09618.HK](https://longbridge.com/en/quote/09618.HK.md) - [03690.HK](https://longbridge.com/en/quote/03690.HK.md) - [00HSI.HK](https://longbridge.com/en/quote/00HSI.HK.md) - [STECH.HK](https://longbridge.com/en/quote/STECH.HK.md) - [JD.US](https://longbridge.com/en/quote/JD.US.md) - [BABA.US](https://longbridge.com/en/quote/BABA.US.md) - [BIDU.US](https://longbridge.com/en/quote/BIDU.US.md) - [89618.HK](https://longbridge.com/en/quote/89618.HK.md) - [89988.HK](https://longbridge.com/en/quote/89988.HK.md) - [HBBD.SG](https://longbridge.com/en/quote/HBBD.SG.md) - [89888.HK](https://longbridge.com/en/quote/89888.HK.md) ## Related News & Research - [Xuanzhu Biopharmaceutical Wins CSRC Nod for H Share Full Circulation Plan](https://longbridge.com/en/news/282442087.md) - [Korean AI chip startup DeepX prepares public share offering](https://longbridge.com/en/news/282627398.md) - [Xuanzhu Biopharm Wins Green Light for Phase III Anaprazole Trial in H. pylori](https://longbridge.com/en/news/282752451.md) - [Xuanzhu Biopharmaceutical Sets March 30 Board Meeting for 2025 Results and Dividend Decision](https://longbridge.com/en/news/279271433.md) - [Barclays Sticks to Its Buy Rating for Alibaba (BABA)](https://longbridge.com/en/news/282639893.md)